Khan J - Search Results

1

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.

Zheng J, Kohler ME, Chen Q, Weber J, Khan J, Johnson BD, Orentas RJ. Zheng J, et al. Among authors: khan j. BMC Immunol. 2007 Mar 30;8:4. doi: 10.1186/1471-2172-8-4. BMC Immunol. 2007. PMID: 17397536 Free PMC article.

2

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.

Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J. Chen QR, et al. Among authors: khan j. BMC Genomics. 2004 Sep 20;5:70. doi: 10.1186/1471-2164-5-70. BMC Genomics. 2004. PMID: 15380028 Free PMC article.

3

Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays.

Bilke S, Chen QR, Whiteford CC, Khan J. Bilke S, et al. Among authors: khan j. Bioinformatics. 2005 Apr 1;21(7):1138-45. doi: 10.1093/bioinformatics/bti133. Epub 2004 Nov 11. Bioinformatics. 2005. PMID: 15539449

4

Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.

Krasnoselsky AL, Whiteford CC, Wei JS, Bilke S, Westermann F, Chen QR, Khan J. Krasnoselsky AL, et al. Among authors: khan j. Oncogene. 2005 Feb 24;24(9):1533-41. doi: 10.1038/sj.onc.1208341. Oncogene. 2005. PMID: 15592497

5

High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma.

Chen QR, Bilke S, Khan J. Chen QR, et al. Among authors: khan j. Cancer Lett. 2005 Oct 18;228(1-2):71-81. doi: 10.1016/j.canlet.2004.12.056. Cancer Lett. 2005. PMID: 15951107 Review.

6

Inferring a tumor progression model for neuroblastoma from genomic data.

Bilke S, Chen QR, Westerman F, Schwab M, Catchpoole D, Khan J. Bilke S, et al. Among authors: khan j. J Clin Oncol. 2005 Oct 10;23(29):7322-31. doi: 10.1200/JCO.2005.03.2821. Epub 2005 Sep 6. J Clin Oncol. 2005. PMID: 16145061

7

Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.

Chen QR, Bilke S, Wei JS, Greer BT, Steinberg SM, Westermann F, Schwab M, Khan J. Chen QR, et al. Among authors: khan j. Genes Chromosomes Cancer. 2006 Sep;45(9):856-62. doi: 10.1002/gcc.20349. Genes Chromosomes Cancer. 2006. PMID: 16804916

8

Gene expression profiles that segregate patients with childhood acute lymphoblastic leukaemia: an independent validation study identifies that endoglin associates with patient outcome.

Catchpoole D, Lail A, Guo D, Chen QR, Khan J. Catchpoole D, et al. Among authors: khan j. Leuk Res. 2007 Dec;31(12):1741-7. doi: 10.1016/j.leukres.2007.04.021. Epub 2007 Jun 18. Leuk Res. 2007. PMID: 17572488

9

An integrated cross-platform prognosis study on neuroblastoma patients.

Chen QR, Song YK, Wei JS, Bilke S, Asgharzadeh S, Seeger RC, Khan J. Chen QR, et al. Among authors: khan j. Genomics. 2008 Oct;92(4):195-203. doi: 10.1016/j.ygeno.2008.05.014. Epub 2008 Jul 30. Genomics. 2008. PMID: 18598751 Free PMC article.

10

Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification.

Bilke S, Chen QR, Wei JS, Khan J. Bilke S, et al. Among authors: khan j. Clin Cancer Res. 2008 Sep 1;14(17):5540-7. doi: 10.1158/1078-0432.CCR-07-4461. Clin Cancer Res. 2008. PMID: 18765546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,168 results

Search Page

Filters